Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Anemia, Diamond-Blackfan
Biological Therapies for Atrial Fibrillation: Ready for Prime Time?
Computer-Assisted Instruction
Solanum tuberosum
Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB.
See All 5 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Biological Therapies for Atrial Fibrillation: Ready for Prime Time?
Donahue JK. Biological Therapies for Atrial Fibrillation: Ready for Prime Time? J Cardiovasc Pharmacol. 2016 Jan; 67(1):19-25.
View in:
PubMed
subject areas
Animals
Anti-Arrhythmia Agents
Atrial Fibrillation
Biological Therapy
Gene Transfer Techniques
Genetic Therapy
Humans
Time Factors
authors with profiles
J. Kevin Donahue MD